Skip to main content
. 2019 Nov 27;98(48):e18244. doi: 10.1097/MD.0000000000018244

Table 3.

Changes in heme oxygenase-1 (HO-1) mRNA level, plasma matrix metalloproteinase-9 (MMP-9), interleukin-1 receptor antagonist (IL-1RA), IL-6, IL-8, IL-10, and lactate concentration in patients receiving TIVA or DES techniques. Values are mean ± SD.

3.